Larvol Delta - OT101-in-Combination-With-Atezolizumab-for-the-Treatment-of-Metastatic-or-Recurrent-NonSmall-Cell-Lung-Cancer

Tecentriq (atezolizumab) - Roche

trabedersen (OT-101) - Autotelic, Oncotelic-Dragon Overseas JV

http://clinicaltrials.gov/ct2/show/NCT05935774

Aug 25, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next